MediT Pen: Engineered for Weekly Dosing
The MediT Pen is ORYN's prefilled injection system, currently available with Tirzepatide 40mg:
Prefilled Precision: Each MediT Pen is factory-filled with the exact weekly dose, eliminating dosing variability and preparation time. Simply remove, inject, and dispose.
Weekly Protocol: Designed for once-weekly administration, mirroring the clinical dosing schedule used in Tirzepatide's landmark SURPASS and SURMOUNT trials. This reduces protocol burden to a single action per week.
Tirzepatide 40mg: Contains 4x the Tirzepatide of the standard pen, delivered in a single weekly dose. The dual GIP/GLP-1 mechanism makes it the most clinically validated compound for metabolic research.
Clinical-Grade Design: The prefilled pen format is the same delivery system used in licensed pharmaceutical products, giving researchers confidence in the delivery mechanism.
NovaDose: Advanced Cartridge Microdosing
The NovaDose represents ORYN's most technologically advanced delivery platform:
Cartridge-Based Design: Instead of a single-use pen, the NovaDose uses replaceable cartridges in a premium reusable aluminium pen body. This creates a sustainable, premium research tool designed for daily use.
Micro-Needle Technology: The NovaDose cartridge system incorporates micro-needles engineered for maximum absorption and minimal discomfort, achieving near-100% bioavailability.
Daily Microdosing Philosophy: The NovaDose is specifically designed for consistent daily microdoses rather than large intermittent doses. This maintains steady-state compound levels that align with the body's natural metabolic rhythms.
NAD+ 500mg: Currently delivers pharmaceutical-grade Korean NAD+ — a compound that benefits particularly from consistent daily dosing to maintain cellular NAD+ pools.
Premium Build: The aluminium pen body is designed for long-term daily use, with an ergonomic design that reflects the premium nature of the NovaDose platform.
Choosing Between MediT and NovaDose
These systems serve different compounds and research goals:
Choose the MediT Pen if: - Your research focuses on metabolic and weight management endpoints - Tirzepatide is the compound you need - Once-weekly dosing suits your protocol - Maximum convenience is a priority - You prefer a familiar prefilled injection pen format
Choose the NovaDose if: - Your research focuses on cellular energy, anti-ageing, or longevity - NAD+ is the compound you need - Daily microdosing is important to your protocol - You want the most advanced delivery technology available - Sustainability (reusable pen) matters to you
Use both if: - Your research spans metabolic and cellular energy endpoints - You are studying the intersection of weight management and cellular ageing - Weekly Tirzepatide + daily NAD+ fits your multi-compound protocol - You want comprehensive coverage of ORYN's advanced delivery platforms
